Nasopharyngeal Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy [NA]
This clinical trial update notes a study evaluating whether immunonutrients reduce oral mucositis in nasopharyngeal carcinoma patients follo…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Occurrence of Radiation-induced Otitis Media in Nasopharyngeal Carcinoma Patients After Intensity Modulated Radiotherapy
The trial is studying the occurrence of radiation-induced otitis media in patients with nasopharyngeal carcinoma treated with intensity modu…
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma [Phase 3]
A Phase III clinical trial evaluating concurrent chemotherapy alone in low-risk nasopharyngeal carcinoma is currently recruiting, sponsored …
-
CLINICAL_TRIALS research · 2024-08-01Clinical Trial Update: Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma. [NA]
A clinical trial comparing endoscopic surgery versus intensity-modulated radiotherapy for Stage I nasopharyngeal carcinoma is currently recr…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma. [NA]
This clinical trial compares two chemoradiotherapy regimens combined with surgery for newly diagnosed operable nasopharyngeal carcinoma. The…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
A multicenter study in China is investigating features of the gut microbiota in patients with several chronic diseases and is currently recr…
-
CLINICAL_TRIALS research · 2024-07-26Clinical Trial Update: Distribution of Bacteria in OME After Radiotherapy For NPC.
This clinical trial update describes the distribution of bacteria in otitis media with effusion after radiotherapy in patients with nasophar…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Penpulimab Combined With GP ± Anlotinib as Neoadjuvant Therapy in Locoregionally Advanced Nasopharyngeal Carcinoma [Phase 2]
A Phase 2 trial is evaluating penpulimab with the GP chemotherapy regimen, with or without anlotinib, as neoadjuvant therapy for locoregiona…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Online Adaptive Radiotherapy for Nasopharyngeal Carcinoma [Phase 3]
This clinical trial update describes an ongoing Phase 3 study of online adaptive radiotherapy for nasopharyngeal carcinoma, which is current…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Tislelizumab in Combination With GP or TPC Regimen for the Treatment of Nasopharyngeal Carcinoma With Bone Metastasis. [Phase 3]
A Phase 3 trial evaluating tislelizumab in combination with GP or TPC regimens for nasopharyngeal carcinoma with bone metastasis is currentl…
-
CLINICAL_TRIALS research · 2024-07-16Clinical Trial Update: Efficacy and Safety of TPC+Apatinib+Camrelizumab vs GP+ Camrelizumab for High-Risk Nasopharyngeal Carcinoma: A Phase 3 Trial [Phase 3]
A Phase 3 clinical trial update comparing TPC+Apatinib+Camrelizumab versus GP+Camrelizumab in high-risk nasopharyngeal carcinoma to assess e…
-
CLINICAL_TRIALS research · 2024-07-08Clinical Trial Update: GP Combined With Nimotuzumab and Sintilimab as Induction Therapy for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial evaluating induction therapy with gemcitabine plus cisplatin in combination with nimotuzumab and sintilimab for locally advanc…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial. [Phase 3]
Phase III open, randomized trial evaluating PFLL with a PD-1 antibody, with or without fecal microbiota transplantation, for oligometastatic…
-
CLINICAL_TRIALS research · 2024-06-28Clinical Trial Update: Exploratory Study of EBV DNA Titre Clearance Whilst on Proton Beam Therapy
This clinical trial update describes an exploratory study to assess clearance of Epstein-Barr Virus DNA titres in patients with nasopharynge…
-
CLINICAL_TRIALS research · 2024-06-26Clinical Trial Update: Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life Study [NA]
This clinical trial update describes a study evaluating manual acupuncture for radiotherapy-induced mucositis in nasopharyngeal carcinoma, u…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma [Phase 2]
Phase 2 clinical trial comparing GP plus adebrelimab versus GP neoadjuvant chemotherapy for nasopharyngeal carcinoma is currently recruiting…
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: Diagnostic Accuracy of EBV C Promoter Methylation Kit in Nasopharyngeal Carcinoma
This clinical trial is evaluating the diagnostic accuracy of an EBV C promoter methylation kit for nasopharyngeal carcinoma and is currently…
-
CLINICAL_TRIALS research · 2024-06-17Clinical Trial Update: Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPC [Phase 2]
Phase II trial update from Shanghai Henlius Biotech evaluating HLX07 + serplulimab + chemotherapy versus placebo + serplulimab + chemotherap…
-
CLINICAL_TRIALS research · 2024-06-04Clinical Trial Update: Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC Patients [NA]
This entry notes a clinical trial investigating a combination of anti-IL6R therapy and anticoagulation in advanced nasopharyngeal carcinoma,…
-
CLINICAL_TRIALS research · 2024-05-02Clinical Trial Update: KSD-101 Therapy for Standard Treatment Failed EBV-associated NPC: an Exploratory Clinical Trial [EARLY_Phase 1]
An early-phase exploratory clinical trial evaluating KSD-101 therapy for EBV-associated nasopharyngeal carcinoma after standard treatment fa…
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC [Phase 3]
Phase 3 trial update noting the addition of a PD-1 inhibitor to neoadjuvant and adjuvant therapy for Nasopharyngeal Carcinoma.
-
CLINICAL_TRIALS research · 2024-05-01Clinical Trial Update: Xerostomia-optimised IMRT Versus Standard IMRT in NPC [NA]
A clinical trial comparing xerostomia-optimised IMRT versus standard IMRT for nasopharyngeal carcinoma to reduce dry mouth during radiothera…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma [Phase 3]
This entry describes an ongoing Phase 3 clinical trial comparing maintenance therapy with toripalimab plus capecitabine versus capecitabine …
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Predictive Study on Acute Radiation Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients
A predictive study evaluating acute radiation-induced oral mucositis in nasopharyngeal carcinoma patients is currently recruiting.
-
CLINICAL_TRIALS research · 2024-04-25Clinical Trial Update: A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors [Phase 1]
This is a Phase 1 clinical trial studying Anti-CD70 UCAR-T for relapsed or refractory solid tumors, with not yet recruiting status.